Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
14°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Turnstone Biologics Corp. - Common Stock
(NQ:
TSBX
)
0.5050
+0.0049 (+0.98%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Turnstone Biologics Corp. - Common Stock
< Previous
1
2
Next >
Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights
November 12, 2024
Portfolio Prioritization and Corporate Restructuring Extends Cash Runway into 2Q 2026
From
Turnstone Biologics Corp.
Via
GlobeNewswire
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 05, 2024
From
Turnstone Biologics Corp.
Via
GlobeNewswire
Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway
October 11, 2024
From
Turnstone Biologics Corp.
Via
GlobeNewswire
Crude Oil Gains Over 1%; Alibaba Posts Weak Revenue
August 15, 2024
Via
Benzinga
Exposures
Fossil Fuels
Nasdaq Jumps Over 2%; Walmart Earnings Top Views
August 15, 2024
Via
Benzinga
Turnstone Biologics Shifts Focus To 'High Unmet Medical Need' Cancers, Shares Initial Data From Colorectal Cancer Cell Therapy Study
August 15, 2024
Turnstone Biologics stock drops after Phase 1 STARLING trial data reveals mixed results for TIDAL-01 in metastatic colorectal cancer, with a 25% response rate.
Via
Benzinga
Dow Surges Over 500 Points; US Retail Sales Rise In July
August 15, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Turnstone Biologics (TSBX) Stock Down 38% Today?
August 15, 2024
Turnstone Biologics stock is down on Thursday as TSBX investors react to the company missing estimates for Q2.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
August 15, 2024
Pre-market stock movers are worth checking out on Thursday morning as we dive into all of the hottest news today!
Via
InvestorPlace
Why Lumentum Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
August 15, 2024
Via
Benzinga
TSBX Stock Earnings: Turnstone Biologics Misses EPS for Q2 2024
August 14, 2024
TSBX stock results show that Turnstone Biologics missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights
August 14, 2024
From
Turnstone Biologics Corp.
Via
GlobeNewswire
Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer
August 14, 2024
From
Turnstone Biologics Corp.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
May 20, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
May 16, 2024
Via
Benzinga
TSBX Stock Earnings: Turnstone Biologics Misses EPS for Q1 2024
May 13, 2024
TSBX stock results show that Turnstone Biologics missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
May 13, 2024
From
Turnstone Biologics Corp.
Via
GlobeNewswire
Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference
May 08, 2024
From
Turnstone Biologics Corp.
Via
GlobeNewswire
Turnstone Biologics Appoints William Waddill to its Board of Directors
April 16, 2024
From
Turnstone Biologics Corp.
Via
GlobeNewswire
TSBX Stock Earnings: Turnstone Biologics Beats EPS for Q4 2023
March 22, 2024
TSBX stock results show that Turnstone Biologics beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights
March 21, 2024
From
Turnstone Biologics Corp.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
March 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 08, 2024
Via
Benzinga
Turnstone Biologics to Participate in Upcoming Investor Conferences
February 21, 2024
From
Turnstone Biologics Corp.
Via
GlobeNewswire
Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.
February 20, 2024
From
Turnstone Biologics Corp.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
February 09, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 23, 2024
Via
Benzinga
Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference
November 27, 2023
From
Turnstone Biologics Corp.
Via
GlobeNewswire
Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
November 09, 2023
From
Turnstone Biologics Corp.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 03, 2023
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
